Evidence map›Paper›PMID 42028629›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer.

Jinpeng Wu, Xueting Ren, Zhen Zhai, Lu Wang, Liang Liang, Zengqi Tan, Jiazhen Zhao, Yuxuan Han, Yuhan Li, Feng Guan and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jinpeng WuKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.
Xueting RenThe Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhen ZhaiThe Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Lu WangKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.
Liang LiangDepartment of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zengqi TanKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.
Jiazhen ZhaoKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.
Yuxuan HanKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.
Yuhan LiInstitute of Molecular and Translational Medicine (IMTM), and Department of Biochemistry and Molecular Biology, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
Feng GuanKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.
Xiang LiKey Laboratory of Resource Biology and Biotechnology in Western China, Provincial Key Laboratory of Biotechnology, College of Life Sciences, Ministry of Education, Northwest University, Xi'an, Shaanxi, China.ORCID https://orcid.org/0000-0003-1857-0055

Funding

National Science Foundation of China 32371336National Science Foundation of China 32501134National Science Foundation of China 82370147National Science Foundation of China 92478123Natural Science Foundation of Shaanxi Province 2025JC-YBQN 260Postdoctoral Fellowship Program of China Postdoctoral Science Foundation GZC20241384Science Foundation for Distinguished Young Scholars of Shaanxi Province 2025JC-JCQN-061Shaanxi Innovation Team Project 2023-CX-TD-58
6 · The paper itself

Abstract

Major histocompatibility complex class I (MHC-I) proteins play a crucial role in immune surveillance by presenting newly synthesized antigens to CD8

Indexed as

AcetylglucosamineAntigen PresentationATP Binding Cassette Transporter, Subfamily B, Member 2Immune EvasionUrinary Bladder NeoplasmsAnimalsCD8-Positive T-LymphocytesHistocompatibility Antigens Class IHumansMiceAcetylglucosamineATP Binding Cassette Transporter, Subfamily B, Member 2Histocompatibility Antigens Class ITAP1 protein, humanTap1 protein, mouseantigen presentationbladder cancermhc‐IO‐GlcNActap1

Identifiers

PMID42028629
PMCPMC13334654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.